End-stage renal disease patients developed left ventricular hypertrophy, Gezira State- Sudan
Abderrhman Ahmed Mohamed Ismaeil1, Nahla Ahmed Mohammed Abderahman2, Mohammed Ahmed Ibrahim Ahmed3, Hiba Abdeen Yousif Osman4
1Associate professor of Physiology, Faculty of Medicine, Sinnar University, Sinnar State, Sudan.
2Assistant professor of Biochemistry, Faculty of Medicine, Department of Biochemistry, Nile Valley University- Atbara, Sudan.
3Assistant professor of Microbiology, Faculty of Medicine, Department of Microbiology, Nile Valley University- Atbara, Sudan.
4University of Gezira, Faculty of medicine, Master Student.
*Corresponding author
*Dr. Nahla Ahmed Mohammed Abdurrahman, Assistant professor of Biochemistry, Nile Valley University,
Faculty of Medicine- Atbara, Sudan.
E-mail: nahlaharazawy@ymail.com.
https://orcid.org/0000-0002-3017-2597
DOI: 10.55920/JCRMHS.2022.01.001022
Table 2: Relationship between different variables and LVH
There is a significant relationship between duration of hemodialysis and LVH P value (0.005 )
Table 3: Relationship between duration of haemodialysis and LVH
- Amoako, Y. A. et al. (2017) ‘Left ventricular hypertrophy among chronic kidney disease patients in Ghana’, Pan African Medical Journal. African Field Epidemiology Network, 28(1), p. 180.
- Armstrong, A. C. et al. (2014) ‘Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: The multi‐ethnic study of atherosclerosis’, Echocardiography. Wiley Online Library, 31(1), pp. 12–20.
- Ayus, J. C. et al. (2005) ‘Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study’, Journal of the American Society of Nephrology. Am Soc Nephrol, 16(9), pp. 2778–2788.
- Bellizzi, V. et al. (2006) ‘Early changes in bioelectrical estimates of body composition in chronic kidney disease’, Journal of the American Society of Nephrology. Am Soc Nephrol, 17(5), pp. 1481–1487.
- Chan, C. T. et al. (2018) ‘Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials’, American journal of nephrology. Karger Publishers, 47(3), pp. 208–217.
- Chang, J.-M. et al. (2014) ‘Anaemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease’, The American journal of the medical sciences. Elsevier, 347(3), pp. 183–189.
- Charytan, D. (2014) ‘Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.’, Current opinion in nephrology and hypertension. England, 23(6), pp. 578–585. doi: 10.1097/MNH.0000000000000067.
- Chobanian, A. V et al. (2003) ‘The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report’, Jama. American Medical Association, 289(19), pp. 2560–2571.
- Cuadrado, L. et al. (2004) ‘Association between hypervolemia and ventricular hypertrophy in hemodialysis patients’, American journal of hypertension. Oxford University Press, 17(12), pp. 1163–1169.
- Ebeid, A. M. et al. (2017) ‘Role of cardiac magnetic resonance imaging and echocardiography in assessing the left ventricle in hemodialysis patients’, Journal of The Egyptian Society of Nephrology and Transplantation. Medknow Publications, 17(1), p. 30.
- Erdan, A. et al. (2018) ‘Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients’, The International journal of artificial organs. SAGE Publications Sage UK: London, England, p. 0391398818778212.
- Fishbane, S., Natke, E. and Maesaka, J. K. (1996) ‘Role of volume overload in dialysis-refractory hypertension’, American journal of kidney diseases. Elsevier, 28(2), pp. 257–261.
- Foley, R. N. et al. (2010) ‘Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease’, Clinical Journal of the American Society of Nephrology. Am Soc Nephrol, p. CJN-07761109.
- group, N. K. F. anaemia working (1997) ‘NKF-K/DOQI clinical practice guidelines for the treatment of anaemia of chronic renal failure’, Am J Kidney Dis, 30(3), pp. S192–S240.
- Hsu, C., McCulloch, C. E. and Curhan, G. C. (2002) ‘Epidemiology of anaemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey’, Journal of the American Society of Nephrology. Am Soc Nephrol, 13(2), pp. 504–510.
- ‘K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.’ (2002) American journal of kidney diseases : the official journal of the National Kidney Foundation. United States, 39(2 Suppl 1), pp. S1-266.
- Kim, E. D. et al. (2015) ‘Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study’, BMC nephrology. BioMed Central, 16(1), p. 131.
- Kim, H. et al. (2015) ‘Risk of major cardiovascular events among incident dialysis patients: A Korean national population-based study.’, International journal of cardiology. Netherlands, 198, pp. 95–101. doi: 10.1016/j.ijcard.2015.06.120.
- Di Lullo, L., Floccari, F. and Polito, P. (2011) ‘Right ventricular diastolic function in dialysis patients could be affected by vascular access’, Nephron Clinical Practice. Karger Publishers, 118(3), pp. c257–c261.
- Ly, J. and Chan, C. T. (2006) ‘Impact of augmenting dialysis frequency and duration on cardiovascular function’, Asaio Journal. LWW, 52(6), pp. e11–e14.
- McCullough, P. A. et al. (2016) ‘Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.’, American journal of kidney diseases : the official journal of the National Kidney Foundation. United States, 68(5S1), pp. S5–S14. doi: 10.1053/j.ajkd.2016.05.025.
- Metivier, F. et al. (2000) ‘Pathophysiology of anaemia: focus on the heart and blood vessels’, Nephrology Dialysis Transplantation. [Berlin; New York, NY]: Springer International,[c1986-, 15(3), pp. 14–18.
- Mominadam, S. et al. (2008) ‘Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients’, Hemodialysis International. Wiley Online Library, 12(3), pp. 322–327.
- Nasri, H. and Baradaran, A. (2005) ‘Effect of anaemia on left ventricular hypertrophy and ejection fraction in maintenance hemodialysis patients’, Timok Medical Journal, 30(2).
- Nitta, K. et al. (2004) ‘Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients’, Hypertension research. The Japanese Society of Hypertension, 27(1), pp. 47–52.
- Oski, F. A. et al. (1971) ‘Exercise with anaemia: the role of the left-shifted or right-shifted oxygen-hemoglobin equilibrium curve’, Annals of internal medicine. Am Coll Physicians, 74(1), pp. 44–46.
- Paoletti, E. et al. (2004) ‘The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey’, Nephrology Dialysis Transplantation, 19(7), pp. 1829–1834. doi: 10.1093/ndt/gfh288.
- Paoletti, E. et al. (2016) ‘Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension’, Clinical Journal of the American Society of Nephrology. Am Soc Nephrol, 11(2), pp. 271–279.
- Pewsner, D. et al. (2007) ‘Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review’, Bmj. British Medical Journal Publishing Group, 335(7622), p. 711.
- Phrommintikul, A. et al. (2007) ‘Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis’, The Lancet. Elsevier, 369(9559), pp. 381–388.
- Regidor, D. L. (2006) ‘Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients’, Journal of the American Society of Nephrology, 17(4), pp. 1181–1191. doi: 10.1681/ASN.2005090997.
- Ritz, E. and Wanner, C. (2008) ‘The challenge of sudden death in dialysis patients’, Clinical Journal of the American society of Nephrology. Am Soc Nephrol, 3(3), pp. 920–929.
- Romhilt, D. W. and Estes Jr, E. H. (1968) ‘A point-score system for the ECG diagnosis of left ventricular hypertrophy’, American heart journal. Elsevier, 75(6), pp. 752–758.
- Shlipak, M. G. et al. (2005) ‘Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors’, Jama. American Medical Association, 293(14), pp. 1737–1745.
- Slinin, Y. et al. (2015) ‘Timing of Dialysis Initiation, Duration and Frequency of Hemodialysis Sessions, and Membrane Flux: A Systematic Review for a KDOQI Clinical Practice Guideline’, American Journal of Kidney Diseases, 66(5), pp. 823–836. doi: https://doi.org/10.1053/j.ajkd.2014.11.031.
- Sokolow, M. and Lyon, T. P. (1949) ‘The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads’, American heart journal. Elsevier, 37(2), pp. 161–186.
- Steddon, S. (2014) Oxford handbook of nephrology and hypertension "2nd". Oxford University Press,pp972.
- Sweety, S. A. et al. (2014) ‘Cardiovascular complications in patients with end stage renal disease on maintenance haemodialysis.’, Mymensingh medical journal: MMJ, 23(2), pp. 329–334.
- Trinh, E. and Chan, C. T. (2016) ‘Intensive Home Hemodialysis Results in Regression of Left Ventricular Hypertrophy and Better Clinical Outcomes.’, American journal of nephrology. Switzerland, 44(4), pp. 300–307. doi: 10.1159/000449452.
- Unver, S. et al. (2015) ‘Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients’, Renal failure. Taylor & Francis, 37(6), pp. 951–956.
- USRDS ANNUAL DATA REPORT (2017) ‘CKD IN THE UNITED STATES Chapter 1: CKD in the General Population’, United States Renal Data System, 1, pp. 1–20. doi: 10.1053/j.ajkd.2016.02.002.
- Vaičiūnienė, R. et al. (2017) ‘Associations Between Left Ventricular Hypertrophy and Hydration Status in Hemodialysis Patients’, 53, pp. 47–51.
- Vanezis, A. P. and Bhopal, R. (2008) ‘Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard’, Journal of electrocardiology. Elsevier, 41(5), pp. 404–412.
- Wabel, P. et al. (2008) ‘Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload’ Nephrology Dialysis Transplantation. Oxford University Press, 23(9), pp. 2965–2971.